General Information of the Compound
Compound ID
CP0060213
Compound Name
US11426393, Compound Table XV.11
    Show/Hide
Synonyms
AKB-6548
    Show/Hide
Structure
Formula
C14H11ClN2O4
Molecular Weight
306.705
Canonical SMILES
OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1
    Show/Hide
InChI
InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)
    Show/Hide
InChIKey
JGRXMPYUTJLTKT-UHFFFAOYSA-N
CAS
1000025-07-9
Physicochemical Property
logP
1.922
Rotatable Bonds
4
Heavy Atom Count
21
Polar Areas
99.52
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 23634441
SID: 46497337
ChEMBL ID
CHEMBL3646221
DrugBank ID
DB12255
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03142, Vascular endothelial growth factor A, long form
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 7600 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( AKB-6548 )
Drug Name AKB-6548
Company Akebia therapeutics
Indication
Anaemia
Phase 3